The DOI matches its Crossref record.
Relationships Between Angiotensin I Converting Enzyme Gene Polymorphism, Plasma Levels, and Diabetic Retinal and Renal Complications
Abstract
Insulin-dependent diabetes mellitus (IDDM), cardiovascular morbidity, and vital prognosis are linked to diabetic nephropathy, which is probably determined by renal hemodynamic abnormalities and by a genetic predisposition. Angiotensin I converting enzyme (ACE) regulates systemic and renal circulations through angiotensin II formation and kinins metabolism. Plasma and cellular ACE levels are genetically determined; an insertion/deletion polymorphism of the ACE gene is strongly associated with ACE levels, subjects homozygote for insertion (genotype II) having the lowest plasma values. We studied the relationship between the ACE gene polymorphism or plasma levels and microcirculatory disorders of IDDM through two independent studies: one involved 57 subjects with or without diabetic retinopathy, and the other compared 62 IDDM subjects with diabetic nephropathy to 62 diabetic control subjects with the same characteristics (including retinopathy severity) but with normal kidney function. The ACE genotype distribution was not different in diabetic subjects with or without retinopathy and in a healthy population. Conversely, an imbalance of ACE genotype distribution, with a low proportion of II subjects, was observed in IDDM subjects with diabetic nephropathy compared with their control subjects (P = 0.006). Plasma ACE levels were mildly elevated in all diabetic groups, independently of retinopathy, but they were higher in subjects with nephropathy than in those without nephropathy (P = 0.0022). The II genotype of ACE gene is a marker for reduced risk for diabetic nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mouse Models of Diabetic Nephropathy
Brosius, F. C., Alpers, C. E., Bottinger, E. P., Breyer, M. D., Coffman, T. M., Gurley, S. B., Harris, R. C., Kakoki, M., Kretzler, M., Leiter, E. H., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070721 · Cited by 895
Staessen, J. A., Wang, J. G., Ginocchio, G., Petrov, V., Saavedra, A. P., Soubrier, F., Vlietinck, R., & Fagard, R. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715120-00059 · Cited by 385
Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes
Ruiz, J., Morabia, A., Blanche, H., James, R. W., Garin, M.-C. B., Charpentier, G., Passa, P., Vaisse, C., Ruiz, J., & Froguel, P. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92709-3 · Cited by 344
Self-citationAngiotensin-converting enzyme inhibitor fetopathy.
Pryde, P. G., Sedman, A. B., Nugent, C. E., & Barr, M. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v391575 · Cited by 332
Marre, M., Jeunemaitre, X., Gallois, Y., Rodier, M., Chatellier, G., Sert, C., Dusselier, L., Kahal, Z., Chaillous, L., Halimi, S., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119321 · Cited by 326
Self-citationQian, Y., Feldman, E., Pennathur, S., Kretzler, M., & Brosius, F. C. (2008) · Diabetes · doi:10.2337/db08-0061 · Cited by 325
Yoshida, H., Mitarai, T., Kawamura, T., Kitajima, T., Miyazaki, Y., Nagasawa, R., Kawaguchi, Y., Kubo, H., Ichikawa, I., & Sakai, O. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118270 · Cited by 322
Laffel, L. M. B., McGill, J. B., & Gans, D. J. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80226-5 · Cited by 279
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease
Garg, J. P., & Bakris, G. L. (2002) · Vascular Medicine · doi:10.1191/1358863x02vm412ra · Cited by 278
Diabetic nephropathy in type II diabetes
Ritz, E., & Stefanski, A. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90538-7 · Cited by 261
Feener, E. P., Northrup, J. M., Aiello, L. P., & King, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117786 · Cited by 255
The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins
Blais, C., Marceau, F., Rouleau, J.-L., & Adam, A. (2000) · Peptides · doi:10.1016/s0196-9781(00)00348-x · Cited by 135
The kallikrein-kinin system in health and in diseases of the kidney
Kakoki, M., & Smithies, O. (2009) · Kidney International · doi:10.1038/ki.2008.647 · Cited by 106
Baboolal, K., Ravine, D., Daniels, J., Williams, N., Holmans, P., Coles, G. A., & Williams, J. D. (1997) · Kidney International · doi:10.1038/ki.1997.373 · Cited by 92
Metadata
- Authors
- Marre, M., Bernadet, P., Gallois, Y., Savagner, F., Guyene, T.-T., Hallab, M., Cambien, F., Passa, P., & Alhenc-Gelas, F.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1994-03-01
- Volume
- 43
- Issue
- 3
- Pages
- 384-388
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2096810815
- Cited by
- 366
- References
- 0
- FWCI
- 27.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.